Manzo Pharmaceut Stock Performance
| MNZO Stock | USD 0.00001 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Manzo Pharmaceut are completely uncorrelated.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Manzo Pharmaceut are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Manzo Pharmaceut displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:10 | Last Split Date 2014-09-17 |
Manzo |
Manzo Pharmaceut Relative Risk vs. Return Landscape
If you would invest 0.00 in Manzo Pharmaceut on September 19, 2024 and sell it today you would earn a total of 0.00 from holding Manzo Pharmaceut or generate 9.223372036854776E16% return on investment over 90 days. Manzo Pharmaceut is currently generating 15.625% in daily expected returns and assumes 125.0% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Manzo, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Manzo Pharmaceut Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Manzo Pharmaceut's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Manzo Pharmaceut, and traders can use it to determine the average amount a Manzo Pharmaceut's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.125
| Best Portfolio | Best Equity | MNZO | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 125.0 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Manzo Pharmaceut is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Manzo Pharmaceut by adding it to a well-diversified portfolio.
Manzo Pharmaceut Fundamentals Growth
Manzo Stock prices reflect investors' perceptions of the future prospects and financial health of Manzo Pharmaceut, and Manzo Pharmaceut fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Manzo Stock performance.
| Current Valuation | 11.6 K | ||||
| Shares Outstanding | 1.16 B | ||||
| Revenue | 2.01 K | ||||
| Gross Profit | 20.97 K | ||||
| EBITDA | (4.24 M) | ||||
| Net Income | (36.24 K) | ||||
| Cash And Equivalents | 21 | ||||
| Total Debt | 11.09 K | ||||
| Cash Flow From Operations | 275.76 K | ||||
| Total Asset | 192.41 K | ||||
| Retained Earnings | (12.4 M) | ||||
| Current Asset | 15 K | ||||
| Current Liabilities | (8 K) | ||||
About Manzo Pharmaceut Performance
By examining Manzo Pharmaceut's fundamental ratios, stakeholders can obtain critical insights into Manzo Pharmaceut's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Manzo Pharmaceut is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. Manzo Pharmaceuticals, Inc. is based in Milford, Pennsylvania. Manzo Pharmaceuticals operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 12 people.Things to note about Manzo Pharmaceut performance evaluation
Checking the ongoing alerts about Manzo Pharmaceut for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Manzo Pharmaceut help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Manzo Pharmaceut is way too risky over 90 days horizon | |
| Manzo Pharmaceut has some characteristics of a very speculative penny stock | |
| Manzo Pharmaceut appears to be risky and price may revert if volatility continues | |
| Manzo Pharmaceut currently holds 11.09 K in liabilities. Manzo Pharmaceut has a current ratio of 0.2, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Manzo Pharmaceut's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 2.01 K. Net Loss for the year was (36.24 K) with profit before overhead, payroll, taxes, and interest of 20.97 K. | |
| Manzo Pharmaceut has a frail financial position based on the latest SEC disclosures |
- Analyzing Manzo Pharmaceut's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Manzo Pharmaceut's stock is overvalued or undervalued compared to its peers.
- Examining Manzo Pharmaceut's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Manzo Pharmaceut's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Manzo Pharmaceut's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Manzo Pharmaceut's stock. These opinions can provide insight into Manzo Pharmaceut's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Manzo Pharmaceut. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Manzo Stock, please use our How to Invest in Manzo Pharmaceut guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Manzo Pharmaceut. If investors know Manzo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Manzo Pharmaceut listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Manzo Pharmaceut is measured differently than its book value, which is the value of Manzo that is recorded on the company's balance sheet. Investors also form their own opinion of Manzo Pharmaceut's value that differs from its market value or its book value, called intrinsic value, which is Manzo Pharmaceut's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Manzo Pharmaceut's market value can be influenced by many factors that don't directly affect Manzo Pharmaceut's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Manzo Pharmaceut's value and its price as these two are different measures arrived at by different means. Investors typically determine if Manzo Pharmaceut is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Manzo Pharmaceut's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.